Cookies on this website
We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.

Oxford University has today been awarded a £2.4 million grant, as part of the Kennedy Trust MB PhD scheme, to fund undergraduate medical students to undertake DPhil research in the areas of inflammation, immunology and musculoskeletal disease.

The scheme will fund 15 students a year for 5 years, 4 of whom will be in Oxford. The other successful Universities Birmingham, Manchester and Glasgow/Edinburgh. The scheme follows the successful launch this year of a BM DPhil educational training program in cancer studies funded by CRUK. Students will be hosted within the Medical Sciences Doctoral training program.

Professor Paul Bowness, Professor of Experimental Rheumatology who led the application, said: "Oxford is thrilled to join the Kennedy Trust MB PhD scheme. This scheme will provide a unique opportunity to educate a new generation of clinician scientists, harnessing Oxford's established research strengths. We are confident these doctors will lead research for the benefit of patients with musculoskeletal diseases many years to come."

Professor Sir Stephen Holgate, The Kennedy Trust's Chairman and MRC Professor of Immunopharmacology at the University of Southampton, said: "The MB PhD initiative combines two of the Kennedy Trust's key aims: investment into translational research and the support of early career scientists. We are delighted to build upon the fantastic programme established by the University of Oxford and we are confident that the Trust's MB PhD scheme will deliver the next generation of clinical academic leaders in musculoskeletal and inflammatory disease research.'"

More details of the Kennedy Trust announcement

Similar stories

Oxford-Bristol Myers Squibb Fellowships awarded to NDORMS researchers

Researchers from the Kennedy Institute of Rheumatology have been awarded fellowships as part of the Oxford-Bristol Myers Squibb Fellowship Programme. Among six researchers from across NDORMS, the programme provides them with an opportunity to gain exposure to the field of commercial drug discovery and development.

Novo Nordisk Postdoctoral Research Fellowship awarded to Inhye Park

Inhye Park has been awarded a Novo Nordisk Postdoctoral Research Fellowship to research the biology of resident vascular macrophages in atherosclerosis.

Researchers from the Kennedy Institute awarded MRC funding

Tonia Vincent, Jelena Bezbradica and Alex Clarke have been awarded funding grants by the Medical Research Council (MRC) for different projects.

New Associate Professors announced at NDORMS

The Medical Sciences Division has awarded the title of Associate Professor to five senior researchers at NDORMS

Doctor Ghada Alsaleh awarded a Versus Arthritis Career Development Fellowship

Postdoctoral Researcher Ghada Alsaleh has been awarded a research grant by Versus Arthritis which she will use to develop a new therapy for osteoarthritis.

EPSRC funds research to avert an antibiotics apocalypse

Researchers at the Kennedy Institute join a collaboration to find new ‘drug-free’ ways of treating illnesses where current treatments have become ineffective due to antibiotic resistance.